Morningstar® Stock Report™

Roche Holding AG ROG

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten29,86%27,74%31,28%32,23%27,06%
Bruttogewinn70,14%72,26%68,72%67,77%72,94%
Vertriebsgemeinkosten24,53%21,63%21,10%19,80%24,62%
Forschung und Entwicklung20,78%22,31%23,56%25,32%23,49%
Umsatzrendite28,55%31,79%28,91%27,62%25,47%
Net Int, Inc and Other55,58%62,60%56,61%53,42%48,76%
EBIT Marge27,03%30,80%27,70%25,80%23,29%
Ertragskraft
20192020202120222023
Steuersatz4,08%4,97%3,92%4,42%2,85%
Nettomarge21,96%24,51%22,18%19,63%19,02%
Gesamtkapitalrendite16,7016,8915,6113,7712,87
Financial Leverage2,542,373,773,153,09
Eigenkapitalsrendite44,7241,3845,8047,3440,13